Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment-resistant bipolar disorder.

M Gitlin1

  • 1Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. mgitlin@mednet.ucla.edu

Molecular Psychiatry
|January 25, 2006
PubMed
Summary

Bipolar disorder treatments, including mood stabilizers and antipsychotics, show promise but often yield inadequate responses. Further research is needed for combination therapies and antidepressant use in bipolar depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2013
Same author

Response to comments on: Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2013
Same author

Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Same author

Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
Same author

Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
Same author

Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia.

The American journal of psychiatry·2001

Area of Science:

  • Psychiatry and Pharmacology
  • Neuroscience
  • Clinical Therapeutics

Background:

  • Bipolar disorder treatment faces challenges with inadequate response rates in acute episodes and maintenance.
  • Established first-line treatments include lithium, valproate, and second-generation antipsychotics (SGAs).
  • Recent advancements include extended-release carbamazepine, lamotrigine, olanzapine, and aripiprazole.

Purpose of the Study:

  • To review current and emerging pharmacologic and non-pharmacologic treatments for bipolar disorder.
  • To address treatment resistance in both manic and depressive episodes.
  • To highlight areas needing further research, particularly combination therapies and antidepressant use.

Main Methods:

  • Literature review of established and recently validated treatments for bipolar disorder.
  • Discussion of treatment strategies for acute mania, bipolar depression, and maintenance therapy.
  • Exploration of approaches for treatment-resistant bipolar disorder, including augmentation and adjunctive therapies.

Main Results:

  • Lithium, valproate, and SGAs are first-line for acute mania; lithium and valproate for maintenance.
  • Anticonvulsants like carbamazepine show promise for mania and maintenance, but require individual evaluation.
  • Adjunctive psychotherapies, high-dose thyroid, clozapine, calcium channel blockers, and ECT are options for treatment resistance.
  • Bipolar depression treatment is evolving, with ongoing debate about antidepressant use; SGAs may play a larger role.

Conclusions:

  • Despite advances, effective bipolar disorder management, especially for treatment resistance and depression, remains a significant clinical challenge.
  • Combination therapy and the role of antidepressants in bipolar disorder require further investigation.
  • Individualized treatment approaches and exploration of under-researched strategies are crucial for improving patient outcomes.

Related Experiment Videos